| Literature DB >> 30113625 |
Christina Gentile1, Blaine Ditto2, Alain Deschamps3, Bianca D'Antono1.
Abstract
BACKGROUND: Little is known about the role of physiological stress responses in metabolic syndrome (MetS).Entities:
Keywords: Autonomic; Heart-rate variability; Metabolic syndrome; Sex differences; Stress
Mesh:
Year: 2019 PMID: 30113625 PMCID: PMC6499413 DOI: 10.1093/abm/kay063
Source DB: PubMed Journal: Ann Behav Med ISSN: 0883-6612
Fig. 1Stress Response Clusters: HR.
Fig. 2Stress Response Clusters: HF-HRV. The geometric mean of HF-HRV is presented on the y-axis.
Number of participants per HR and HF-HRV cluster
| HR | Total sample | Men | Women |
|---|---|---|---|
| Cluster 1 | 756 | 503 (80%) | 253 (72%) |
| Cluster 2 | 224 | 126 (20%) | 98 (28%) |
There is a significant sex difference in HR cluster composition, χ2 = 7.95, p = .005.
There is no significant sex difference in HF-HRV cluster composition, χ2 = 0.92, p = .63.
Summary of participant characteristics, M (SD)
| Men | Women | |
|---|---|---|
| ( | ( | |
| Age (years) | 65.3 (6.9) | 64.9 (7.5) |
| Body Mass Index* (kg/m2) | 29.5 (4.8) | 28.8 (6.2) |
| Presence of CAD***, | 475 (68%) | 112 (28.5%) |
| Presence of metabolic syndrome**, | 414 (59.1%) | 190 (48.3%) |
| Smoker*, | 82 (11.7%) | 31 (7.9%) |
| Hours of exercise/week | 3.2 (3.8) | 3.1 (3.2) |
| Years of schooling* | 14.5 (3.7) | 14.0 (3.7) |
| Marital Status***, | ||
| Single | 52 (7.4%) | 46 (11.7%) |
| Married/living with someone | 544 (77.7%) | 259 (65.9%) |
| Separated/divorced/widowed | 104 (14.9%) | 88 (22.4%) |
| Annual household income***, | ||
| ≤$39,999 | 120 (17.2%) | 93 (23.7%) |
| $40,000–59,999 | 153 (21.9%) | 115 (29.3%) |
| $60,000–99,999 | 230 (32.9%) | 104 (26.5%) |
| ≥$100,000 | 194 (27.7%) | 69 (17.6%) |
|
| ||
| SBP*** (mm Hg) | 143.9 (20.0) | 138.4 (22.2) |
| DBP*** (mm Hg) | 73.2 (13.0) | 70.1 (13.7) |
| Waist circumference*** (cm) | 102.9 (13.6) | 92.7(15.4) |
| Glucose*** (mmol/L) | 6.4(1.4) | 5.9 (1.2) |
| Triglycerides (mmol/L) | 1.7 (0.8) | 1.6 (0.8) |
| HDL cholesterol*** (mmol/L) | 1.2 (0.3) | 1.5 (0.4) |
|
| ||
| HR*** (bpm) | 62.3 (9.8) | 67.4 (9.4) |
| HF-HRV** (ms2) | 827.0 (2990.3) | 365.1 (1014.3) |
| LF/HF | 2.51 (6.34) | 2.43 (2.83) |
| HFnu | 0.43 (0.2) | 0.41 (0.2) |
N may vary slightly depending on measure. CAD = coronary artery disease, SBP = systolic blood pressure, DBP = diastolic blood pressure, HDL = high-density lipoprotein cholesterol, HR = heart rate, HF-HRV = high-frequency heart-rate variability, HFnu = high-frequency heart-rate variability in normalized units. Significant sex differences for each variable are indicated with asterisks, *p < .05, **p < .01, ***p < .001.
Multiple logistic regression model for metabolic syndrome using HR cluster as independent variable
| OR (95% CI) |
| |
|---|---|---|
| HR Cluster (Cluster 2 vs. Cluster 1) | 1.45 (1.02–2.07) | .04 |
| Sex (male vs. female) | 1.35 (0.94–1.93) | .10 |
| Age (1 SD = 7.0 year increase in age) | 1.04 (0.89–1.22) | .64 |
| Presence of CAD | 0.98 (0.69–1.39) | .91 |
| BMI (1 SD = 5.3 kg/m2 increase in BMI) | 3.46 (2.77–4.32) | <.001 |
| Exercise (hours/week) (1 SD=3.6 hour increase in exercise) | 0.92 (0.79–1.06) | .25 |
| Household income | ||
| $40,000–59,999 vs. ≤$39,999 | 0.80 (0.51–1.27) | .35 |
| $60,000–99,999 vs. ≤$39,999 | 0.66 (0.42–1.03) | .07 |
| ≥$100,000 vs. ≤$39,999 | 0.57 (0.34–0.93) | .03 |
| Years of school | 0.95 (0.80–1.11) | .50 |
| Medication influencing MetS parameters | 1.19 (0.72–1.94) | .50 |
| Other medications | 1.61 (0.80–3.23) | .18 |
| Presence of comorbid medical conditions | 1.50 (1.10–2.04) | .01 |
| Sex hormone therapy | 0.63 (0.32–1.27) | .20 |
OR = odds ratio, CI = confidence interval, SBP = systolic blood pressure, BMI = body mass index, CAD = coronary artery disease.
Multiple logistic regression model for metabolic syndrome using HF-HRV cluster as independent variable and sex as moderator
| OR (95% CI) |
| |
|---|---|---|
| Sex × HF Cluster† | .005 | |
| Cluster 2 vs. Cluster 1 within female | 2.30 (1.30–4.07) | .004 |
| Cluster 3 vs. Cluster 1 within female | 2.57 (1.22–5.41) | .01 |
| Cluster 2 vs. Cluster 3 within female | 0.90 (0.44–1.84) | .77 |
| Cluster 2 vs. Cluster 1 within male | 0.69 (0.46–1.02) | .06 |
| Cluster 3 vs. Cluster 1 within male | 0.59 (0.35–1.00) | .05 |
| Cluster 2 vs. Cluster 3 within male | 1.16 (0.69–1.92) | .58 |
| Cluster† | .40 | |
| Sex (male vs. female)ψ | 1.32 (0.92–1.90) | .13 |
| Age (1 SD=7.0 year increase in age) | 1.02 (0.86–1.19) | .85 |
| Presence of CAD | 0.94 (0.66–1.33) | .72 |
| BMI (1 SD=5.3 kg/m2 increase in BMI) | 3.50 (2.80–4.37) | <.001 |
| Exercise (hours/week) (1 SD=3.6 hour increase in exercise) | 0.91 (0.78–1.05) | .21 |
| Household income | ||
| $40 000–59,999 vs. ≤$39,999 | 0.83 (0.52–1.32) | .42 |
| $60,000–99,999 vs. ≤$39,999 | 0.68 (0.43–1.07) | .09 |
| ≥$100,000 vs. ≤$39,999 | 0.59 (0.36–0.97) | .04 |
| Years of school | 0.94 (0.77–1.10) | .43 |
| Medication influencing MetS parameters | 1.29 (0.78–2.13) | .32 |
| Other medications | 1.54 (0.76–3.11) | .23 |
| Presence of comorbid medical conditions | 1.52 (1.11–2.07) | <.01 |
| Sex hormone therapy | 0.62 (0.30–1.25) | .18 |
OR = odds ratio, CI = confidence interval, SBP = systolic blood pressure, BMI = body mass index, CAD = coronary artery disease.